Insights

Gathering insights about AMIS…

Similar companies to AMIS

AMIS Tech Stack

AMIS uses 8 technology products and services including Google Cloud CDN, WordPress, Lightbox, and more. Explore AMIS's tech stack below.

Google Cloud CDN
Content Delivery Network
WordPress
Content Management System
Lightbox
Javascript Libraries
Lodash
Javascript Libraries
Ubuntu
Operating Systems
Yoast SEO
Search Engines
Ionicons
Web Fonts
WPForms
Web Platform Extensions

Media & News

Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus
Company to begin trading under new ticker symbol “DMK” on September 8, 2023 Company to begin trading under new ticker symbol “DMK” on September 8, 2023
Sep 07, 2023 | www.globenewswire.com
Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2023, and provided an update on recent corporate developments.
Aug 21, 2023 | www.globenewswire.com
Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering of 5,930,000 units, with each unit consisting of one share of common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase one share of common stock. Each unit was sold at a public offering price of $1.35. The common warrants are immediately exercisable at a price of $1.35 per share and expire five years from the date of issuance. The shares of common stock (or pre-funded warrants in lieu thereof) and accompanying common warrants were only purchasable together in this offering, but were issued separately and immediately separable upon issuance.
Aug 04, 2023 | www.globenewswire.com
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the pricing of its public offering of 5,930,000 units at a public offering price of $1.35 per unit. Each unit consists of one share of common stock (or a prefunded warrant in lieu thereof) and one warrant to purchase one share of common stock. The common warrants will be immediately exercisable at an exercise price of $1.35 per share and will expire five years from the date of issuance. The shares of common stock (or pre-funded warrants in lieu thereof) and accompanying common warrants can only be purchased together in this offering, but will be issued separately and will be immediately separable upon issuance.
Aug 02, 2023 | www.globenewswire.com
Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the Company has committed to fund an unrestricted research grant to the Leiden University Medical Center (LUMC) Anesthesia and Pain Research Unit. The funding will support the work of Albert Dahan, MD, PhD, a world expert on opioid-induced respiratory depression (opioid overdose) and professor of anesthesiology at the University. Dr. Dahan has been working with the FDA since 2020 to understand better methods of reversing fentanyl overdoses.
Jul 28, 2023 | www.globenewswire.com
Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use Disorder
SAN DIEGO, June 26, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced that its wholly owned subsidiary DMK Pharmaceuticals Corporation was the recipient of a grant from the National Institute on Alcohol Abuse And Alcoholism (NIAAA) of the National Institutes of Health (NIH) to support the development of a novel bifunctional small molecule for the treatment of Alcohol Use Disorder (AUD) (#R41AA030226).
Jun 26, 2023 | www.globenewswire.com
Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose Prevention
SAN DIEGO, June 22, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced that Eboo Versi, MD, PhD, CEO of Adamis Pharmaceuticals is proud and excited to have participated in the White House Roundtable with Opioid Reversal Product Manufacturers, hosted by White House Office of National Drug Control Policy Director, Dr. Rahul Gupta, White House Domestic Policy Council Advisor Neera Tanden, U.S. Assistant Secretary for Health Admiral Rachel Levine, and U.S. Assistant Secretary for Mental Health and Substance Use Dr. Miriam E. Delphin-Rittmon. Dr. Gupta is the first medical doctor to ever lead the White House Office of National Drug Control Policy (ONDCP). ONDCP is responsible for the development and implementation of the National Drug Control Strategy and Budget. The roundtable discussion was held on June 20, 2023.
Jun 22, 2023 | www.globenewswire.com

AMIS's Email Address Formats

AMIS uses at least 1 format(s):

AMIS Email Formats	Example	Percentage
FLast@amis.com.mx	JDoe@amis.com.mx	45%
FiMLast@amis.com.mx	JoMDoe@amis.com.mx	5%
FLast@amis.com.mx	JDoe@amis.com.mx	45%
FiMLast@amis.com.mx	JoMDoe@amis.com.mx	5%

Frequently Asked Questions

Where is AMIS's headquarters located?

AMIS's main headquarters is located at Francisco I. Madero #21Col. Tlacopac, San Ángel Ciudad de México, Álvaro Obregón 01040 MX. The company has employees across 5 continents, including North AmericaAsiaSouth America.

What is AMIS's stock symbol?

AMIS is a publicly traded company; the company's stock symbol is ADMP.

What is AMIS's official website and social media links?

AMIS's official website is amis.com.mx and has social profiles on LinkedIn.

How much revenue does AMIS generate?

As of August 2024, AMIS's annual revenue reached $15M.

What is AMIS's NAICS code?

AMIS's NAICS code is 524 - Insurance Carriers and Related Activities.

How many employees does AMIS have currently?

As of August 2024, AMIS has approximately 352 employees across 5 continents, including North AmericaAsiaSouth America. Key team members include Vice President Insurance Association Mexico (amis): N. R.Cybersecurity President At The Association Of Mexican Insurance Companies (amis): M. P. B.Cfo - Director Of Finance And Administration: R. C.. Explore AMIS's employee directory with LeadIQ.

What industry does AMIS belong to?

AMIS operates in the Insurance industry.

What technology does AMIS use?

AMIS's tech stack includes Google Cloud CDNWordPressLightboxLodashUbuntuYoast SEOIoniconsWPForms.

What is AMIS's email format?

AMIS's email format typically follows the pattern of . Find more AMIS email formats with LeadIQ.

When was AMIS founded?

AMIS was founded in 1964.

AMIS

InsuranceÁlvaro Obregón, Mexico201-500 Employees

Nuestro principal objetivo es el desarrollo de la industria aseguradora, representar sus intereses ante el sector público, privado y social, además de promover la cultura de la prevención de riesgos y el seguro como mecanismo de protección.

Company Overview

Headquarters: Francisco I. Madero #21Col. Tlacopac, San Ángel Ciudad de México, Álvaro Obregón 01040 MX
Website: amis.com.mx
Stock Symbol: ADMP
NAICS Code: 524 - Insurance Carriers and Related Activities
Founded: 1964
Employees: 201-500

Media & News

Funding & Financials

$10M$50M
AMIS's revenue is in the range of $10M$50M

Funding & Financials

$10M$50M
AMIS's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to AMIS

OIV

Metronet

H1 TELEKOM

AMIS Tech Stack

Media & News

Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus

Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering

Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering

Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert

Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use Disorder

Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose Prevention

AMIS's Email Address Formats

Frequently Asked Questions

Where is AMIS's headquarters located?

What is AMIS's stock symbol?

What is AMIS's official website and social media links?

How much revenue does AMIS generate?

What is AMIS's NAICS code?

How many employees does AMIS have currently?

What industry does AMIS belong to?

What technology does AMIS use?

What is AMIS's email format?

When was AMIS founded?

AMIS

Company Overview

Media & News

Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus

Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?